SGLT2 inhibitors → TIM-3 — Novel Hypothesis | InTree.AI

Novel Hypothesis

SGLT2 inhibitorsTIM-3

SGLT2 inhibitors reduce TIM-3 expression on exhausted T cells, restoring effector function

Convergence: 69%1 bridgeimmunology

Bridge Entities

PD-1A→B quality: 0.70B→C quality: 0.70

SGLT2 inhibitors PARTICIPATES IN PD-1, which CONNECTED TO TIM-3

A→B Evidence (23 total)

“Moreover, it was reported that like PD-1 the classical exhaustion marker, TIM-3 is up-regulated in exhausted murine and human T cells and TIM-3 blockade was described to restore the function of these T cells.”— TIM-3 does not act as a receptor for galectin-9. (2013)DOI

Why This Is Novel

No published papers mention both SGLT2 inhibitors and TIM-3 together. This connection is entirely inferred through PD-1 — a genuinely unexplored hypothesis.

Discovered by InTree.AI — analyzing 250M+ scientific papers

Bridge Entities

Why This Is Novel

Under Maintenance

Bridge Entities

Why This Is Novel